| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |